Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-11-07
2006-11-07
Saeed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S422000, C514S423000, C548S423000, C548S530000, C546S208000, C546S278400, C544S360000, C544S372000
Reexamination Certificate
active
07132434
ABSTRACT:
Compounds of the formula (I), useful as metal-loproteinase inhibitors, especially as inhibitors of MMP12
REFERENCES:
patent: 2745875 (1956-05-01), Ehrhart et al.
patent: 3452040 (1969-06-01), Langis
patent: 3529019 (1970-09-01), Suh et al.
patent: 3849574 (1974-11-01), Suh et al.
patent: 4241073 (1980-12-01), Jamieson et al.
patent: 4315031 (1982-02-01), Vincent et al.
patent: 5068187 (1991-11-01), Takeichi et al.
patent: 5246943 (1993-09-01), Blankley et al.
patent: 5308853 (1994-05-01), Hodges et al.
patent: 5521187 (1996-05-01), Freyne et al.
patent: 5804593 (1998-09-01), Warpehoski et al.
patent: 5917790 (1999-06-01), Ohta et al.
patent: 5955435 (1999-09-01), Baxter et al.
patent: 6046214 (2000-04-01), Kristiansen et al.
patent: 6048841 (2000-04-01), Baxter et al.
patent: 6114361 (2000-09-01), Robinson et al.
patent: 6159995 (2000-12-01), Thorwart et al.
patent: 6166041 (2000-12-01), Cavalla et al.
patent: 6218418 (2001-04-01), Pevarello et al.
patent: 6268379 (2001-07-01), Xue et al.
patent: 6277987 (2001-08-01), Kukkola et al.
patent: 6329418 (2001-12-01), Cheng et al.
patent: 6339101 (2002-01-01), Ross et al.
patent: 6340691 (2002-01-01), Levin et al.
patent: 6429213 (2002-08-01), Xue et al.
patent: 6890915 (2005-05-01), Sheppeck et al.
patent: 6906053 (2005-06-01), Sheppeck et al.
patent: 2002/0006920 (2002-01-01), Robinson et al.
patent: 2002/0028835 (2002-03-01), Hu et al.
patent: 2002/0065219 (2002-05-01), Naidu et al.
patent: 2002/0091107 (2002-07-01), Madar et al.
patent: 2003/0130273 (2003-07-01), Sheppeck et al.
patent: 2004/0106659 (2004-06-01), Af Rosenschold
patent: 2004/0110809 (2004-06-01), Lepisto et al.
patent: 2004/0116486 (2004-06-01), Lepisto et al.
patent: 2004/0127528 (2004-07-01), Eriksson et al.
patent: 2004/0138276 (2004-07-01), Eriksson et al.
patent: 2004/0147573 (2004-07-01), Eriksson et al.
patent: 2004/0152697 (2004-08-01), Chan et al.
patent: 2004/0209874 (2004-10-01), Sheppeck et al.
patent: 2005/0019994 (2005-01-01), Chang
patent: 2005/0171096 (2005-08-01), Sheppeck et al.
patent: 2005/0245586 (2005-11-01), Henriksson et al.
patent: 2005/0256176 (2005-11-01), Burrows et al.
patent: 2006/0063818 (2006-03-01), Burrows et al.
patent: 212617 (1986-08-01), None
patent: 0486280 (1991-11-01), None
patent: 0640594 (1995-03-01), None
patent: 0709375 (1995-10-01), None
patent: 1191024 (2002-03-01), None
patent: 1117616 (2003-04-01), None
patent: 02 74 1724 (2004-03-01), None
patent: WO 95/14025 (1994-11-01), None
patent: WO 96/27583 (1996-09-01), None
patent: WO 1996/27583 (1996-09-01), None
patent: WO 98/50359 (1998-05-01), None
patent: WO 99/06361 (1999-02-01), None
patent: WO 99/42443 (1999-02-01), None
patent: WO 99/24399 (1999-05-01), None
patent: WO 00/09103 (1999-08-01), None
patent: WO 00/35886 (1999-12-01), None
patent: WO 00/12477 (2000-03-01), None
patent: WO 00/12478 (2000-03-01), None
patent: WO 00/40577 (2000-07-01), None
patent: WO 00/75106 (2000-12-01), None
patent: WO 01/05756 (2001-01-01), None
patent: WO 01/12189 (2001-02-01), None
patent: WO 01/22363 (2001-03-01), None
patent: WO 01/34573 (2001-05-01), None
patent: WO 02/006232 (2002-01-01), None
patent: WO 02/014262 (2002-02-01), None
patent: WO 02/014354 (2002-02-01), None
patent: WO 02/020515 (2002-03-01), None
patent: WO 02/074749 (2002-09-01), None
patent: WO 02/074751 (2002-09-01), None
patent: WO 02/074752 (2002-09-01), None
patent: WO 02/074767 (2002-09-01), None
patent: WO 02074748 (2002-09-01), None
patent: WO 02074750 (2002-09-01), None
patent: WO 02/96426 (2002-12-01), None
patent: WO 03/040098 (2003-05-01), None
patent: WO 2004/020415 (2004-03-01), None
patent: WO 2004/024060 (2004-03-01), None
patent: WO 2004/024698 (2004-03-01), None
patent: WO 2004/024715 (2004-03-01), None
patent: WO 2004/024718 (2004-03-01), None
patent: WO 2004/024721 (2004-03-01), None
Aimoto, et al. “Synthesis of Carriers of Differing Strokes Radius with Activated Acyl Groups for Use as Reagents in Labeling Membrane Proteins,” Journal of Biological Chemistry, vol. 256(10), pp. 5134-5143, 1981.
Michaelides et al., “Recent Advances in Matrix Metalloproteinase Inhibitors Research”,Current Pharmaceutical Design5:787-819 (1999).
Mock et al., “Principles of Hydroxamate Inhibition of Metalloproteases: Carboxypeptides A”,Biochemistry39:13945-13952 (2000).
Aharony et al. “Pharmacological Characterization of a New Class of Nonpeptide Neurokinin A Antagonists that Demonstrate Species Selectivity.” J. Pharmacol. Exp. Ther. 274:3 (1995), pp. 1216-1221.
Aimoto et al. “Synthesis of Carriers of Differing Strokes Radius with Activated Acyl Groups for Use as Reagents in Labeling Membrane Proteins.” Journal of Biological Chemistry, vol. 256(10), pp. 5134-5143, 1981.
Chemical Abstracts, vol. 65, 1966, ABSTRACT No. 13684 h, M. Lora-Tamayo et al.: “Potential anticancer agents. I. Glutamine sulfonate analogs”, & Anales Real Soc. Espan. Fis. Quim (Madrid), Ser. B. 62(2), 173-86.
Croce, P. et al. “Stereoselective aldol addition of a chirai glycine enloate synthon to heteroaromatic aldehydes.” Heterocycles, 52:3 (2000) pp. 1337-1344.
Knabe, J. “Razemate und enantiomere basisch substituierter 5-phenylhydantoine.” Pharmazie. 52:12 (1997) pp. 912-919.
Bright et al. “Monoclonal Antibodies as Surrogate Receptors in High Throughput Screen for Compounds that Enhance Insulin Sensitivity.” Life Sciences. 61:23 (1997), pp. 2305-2315.
Lora-Tamayo et al. “anticancerousos Potenciales.” An. Quim. 64:6 (1968), pp. 591-606.
Miyake, Toshiaki et al. “Studies on Glycosylation of erythro-Beta-Hydroxy-L-histidine. A Key Step of Blemycin Total Synthesis.” Bull. Chem. Soc. Jpn. 59 (1986), pp. 1387-1395.
Nakajima, Riichiro et al. “The utility of 4-(2-thienyl)pyridines as a derivatization reagent for hplc and ce.” Analytical Sciences. 7, Supplement 1991, pp. 177-180.
Nicolet, Ben. “Interpretation of the Dyhydration of Acetylglutamic acid by Means of Glutamylthiohydantoin Derivatives.” Journal of the American Chemical Society, 1930, pp. 1192-1195.
Owa, Takashi et al. “Man-Designed Bleomycins: Significance of the binding Sites as Enzyme Models and of the Stereochemistry of the Linker Moiety.” Tetrahedron. 48:7 (1992) pp. 1193-1208.
Peng, Sean X. “Separation and identification of methods for metalloproteinase inhibitors.” Journal of Chromatography B. 764 (2001), pp. 59-80.
Saito, Sei-ichi et al. “A new synthesis of deglyco-bleomycine A2 aiming at the total synthesis of bleomycin.” Tetrahedron Letters. 23(5) (1982), pp. 529-532.
STN International, file CAPLUS, accession No. 1978:424767, Raulais, Daniel J.P., “Synthesis and characterization of phenylthiohydantoin derivatives of amino-acids protected in their sid-chain functions, and their application for monitoring olid-phase peptide synthesis,” & Journal of Chemical Research, Synopses (1978), p. 11.
STN International, file CAPLUS, accession No. 1994:299315, Document No. 120:299315, Sakamoto, Shuichi et al., “Preparation of pyridylserine derivatives as psychotropics,” WO, A1, 9320053, 1931014, See CAS RN 154696-31-8, 154697-48-0.
STN International, file CAPLUS, accession No. 1997:644516, Batty, Craig et al. “Synthesis and exchange reaction of 5-alkyl-2oxo-6-thioxo-1,2,3,6-hexahydropyrimidine-4-carboxylic acids” & Journal of Heterocyclic Chemistry (1997), 34:3, 1355-1367.
STN International, file CAPLUS, accession No. 2002:640897, Gooding, Owen W. et al. “Use of Statistical Design of Experiments in the Optimization of Amide Synthesis Utilizing Polystryene-Supported N-Hydroxybenzotriazole Resin” & Journal of Combinatorial Chemistry (2002), 4(6), 576-583.
STN International, File CAPLUS, CAPLUS accession No. 1968:506154, Doc. No. 69:106154, Lora-Tamayo, J. et al.: “Potential anticancer agents, VI. Sulfonic analogs of aspartic acid”, & An. Quim. (1968), 64(6), 591-606.
STN International, F
Af Rosenschöld Magnus Munck
Eriksson Anders
Lepistö Matti
Lundkvist Michael
Stenvall Kristina
AstraZeneca AB
Fish & Richardson P.C.
Grazier Nyeemah
Saeed Kamal A.
LandOfFree
Metalloproteinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Metalloproteinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Metalloproteinase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3648241